# OnCo record valrubicin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/valrubicin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "valrubicin" ;
  schema:name "Valrubicin"@en ;
  schema:description "Valrubicin (Valstar) is a chemotherapy washed into the bladder for carcinoma in situ that has not responded to BCG, in patients who cannot yet have their bladder removed."@en ;
  schema:url <https://onco.cc/drugs/valrubicin/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Valrubicin> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=valrubicin>, <https://www.cancer.gov/about-cancer/treatment/drugs/valrubicin> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "Anthracycline (intravesical)" ;
  schema:alternateName "Valstar" ;
  onco:approval "US 1998: Intravesical therapy of BCG-refractory carcinoma in situ of the bladder when immediate cystectomy is not acceptable" ;
  onco:related <https://onco.cc/drugs/nadofaragene-firadenovec/>, <https://onco.cc/drugs/nogapendekin-alfa/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/bcg-and-intravesical-therapy/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:companies <https://onco.cc/companies/endo/> ;
  onco:trials <https://onco.cc/trials/nct01310803/> .